rxstat › Shortages › Indapamide
Indapamide shortage status
Partial shortage
Source: Health Canada shortage reports · Updated Jul 9, 2026
Some Indapamide products are in shortage in Canada (2 of 14 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Dec 31, 2020.
In shortage since
Sep 15, 2016
Est. full return
Dec 31, 2020
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.
Reports by product
Active shortageJAMP-INDAPAMIDE
1.25MG · TABLET · JAMP PHARMA CORPORATION
DIN 02373904 · since Sep 15, 2016, est. end Dec 31, 2020 · Other (Please describe in comments)
Active shortageJAMP-INDAPAMIDE
2.5MG · TABLET · JAMP PHARMA CORPORATION
DIN 02373912 · since Sep 15, 2016, est. end Dec 31, 2020 · Other (Please describe in comments)
Active shortageJAMP-INDAPAMIDE
2.5MG · TABLET · JAMP PHARMA CORPORATION
DIN 02373912 · since Sep 15, 2016, est. end Dec 31, 2020 · Other (Please describe in comments)
Active shortageJAMP-INDAPAMIDE
2.5MG · TABLET · JAMP PHARMA CORPORATION
DIN 02373912 · since Sep 15, 2016, est. end Dec 31, 2020 · Other (Please describe in comments)
AnticipatedMYLAN-INDAPAMIDE
1.25MG · TABLET · MYLAN PHARMACEUTICALS ULC
DIN 02240067 · Disruption of the manufacture of the drug.
ResolvedRIVA-INDAPAMIDE 1.25
1.25MG · TABLET · LABORATOIRE RIVA INC
DIN 02247245 · ended Apr 1, 2026 · Disruption of the manufacture of the drug.
ResolvedRIVA-INDAPAMIDE 2.5 MG
2.5MG · TABLET · LABORATOIRE RIVA INC
DIN 02242125 · ended Apr 1, 2026 · Disruption of the manufacture of the drug.
ResolvedMYLAN-INDAPAMIDE
1.25MG · TABLET · MYLAN PHARMACEUTICALS ULC
DIN 02240067 · ended Apr 17, 2026 · Disruption of the manufacture of the drug.
ResolvedMYLAN-INDAPAMIDE
2.5MG · TABLET · MYLAN PHARMACEUTICALS ULC
DIN 02153483 · ended Mar 30, 2026 · Disruption of the manufacture of the drug.
ResolvedMYLAN-INDAPAMIDE
1.25MG · TABLET · MYLAN PHARMACEUTICALS ULC
DIN 02240067 · ended Nov 26, 2025 · Disruption of the manufacture of the drug.
ResolvedMYLAN-INDAPAMIDE
2.5MG · TABLET · MYLAN PHARMACEUTICALS ULC
DIN 02153483 · ended Oct 8, 2025 · Disruption of the manufacture of the drug.
ResolvedMYLAN-INDAPAMIDE
1.25MG · TABLET · MYLAN PHARMACEUTICALS ULC
DIN 02240067 · ended Sep 3, 2025 · Disruption of the manufacture of the drug.
Showing 12 of 56 reports. All reports are on file with Health Canada.
What's happening
Indapamide is currently affected by 2 active shortage reports filed with Health Canada by JAMP PHARMA CORPORATION.
The reported cause is: other (please describe in comments). Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Indapamide is classified under “LOW-CEILING DIURETICS, EXCL THIAZIDES” (ATC C03BA).
Recent changes
Common questions
When will Indapamide be back in stock in Canada?
The latest manufacturer estimate is Dec 31, 2020. Estimates are self-reported and often slip; this page updates automatically when they change.
Why is Indapamide in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Guides: what to do when your medication is in shortage · how to read shortage reports
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.